Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-03

Clinical Trial Update: Malaria High-Risk Populations in Namibia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update focused on malaria in high-risk populations in Namibia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Malaria | Phase 4 | Status: COMPLETED